A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission
Edward K. Kasper, MD, FACC*,*,
Gary Gerstenblith, MD, FACC*,
Gail Hefter, CRNP*,
Elizabeth Van Anden, PA-C*,
Jeffrey A. Brinker, MD, FACC*,
David R. Thiemann, MD*,
Michael Terrin, MD ,
Sandra Forman, MA and
Sheldon H. Gottlieb, MD, FACC*
* Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Maryland Medical Research Institute, Baltimore, Maryland, USA

View larger version (12K):
[in a new window]
|
Figure 1 Life-table first event rates for death or readmission for chronic heart failure. The trial end point was 180 days or six months (p = 0.12 by log-rank). This was not the primary end point, which was death or all readmissions for chronic heart failure.
|
|
|